A federal appeals court in New York on Thursday upheld an order blocking the sale of “gray market” versions of Abbott Laboratories’ diabetes test strips.
Abbott is suing distributors and pharmacies over domestic sales of the international version of the company’s Freestyle blood glucose strips. Last year, a federal judge in Brooklyn issued a preliminary injunction halting U.S. sales of the products.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
